Thomas James Doyle
SVP, Finance & Accounting · 1 filing · Latest: Jan 27, 2026
Kura Oncology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KURA | Thomas James Doyle | SVP, Finance & Accounting | Jan 27, 2026 | Sale | $8.46 | 7,142 | $60.4K | 145,167 | |
KURA | DOYLE THOMAS JAMES | — | Jan 27, 2026 | Proposed Sale | $8.47 | 7,142 | $60.5K | — | |
KURA | DOYLE THOMAS JAMES | — | Nov 14, 2025 | Proposed Sale | $10.68 | 4,539 | $48.5K | — | |
KURA | DOYLE THOMAS JAMES | — | Sep 29, 2025 | Proposed Sale | $9.05 | 4,541 | $41.1K | — | |
KURA | DOYLE THOMAS JAMES | — | Jan 28, 2025 | Proposed Sale | $7.77 | 4,949 | $38.5K | — |